Encompass Health Corp (NYSE:EHC)
$ 102.94 0.1 (0.1%) Market Cap: 10.37 Bil Enterprise Value: 13.01 Bil PE Ratio: 24.86 PB Ratio: 5.30 GF Score: 82/100

Encompass Health Corp at UBS Global Healthcare Conference Transcript

May 24, 2022 / 01:15PM GMT
Release Date Price: $50.57 (-0.72%)
Andrew Mok
UBS Investment Bank, Research Division - Analyst

Hi. Good morning, and welcome back to the UBS Healthcare Conference. My name is Andrew Mok. I'm the U.S. health care providers analyst at UBS. And I'm pleased to be joined on stage with Encompass CEO, Mark Tarr; and Encompass CFO, Doug Coltharp. Welcome.

Mark J. Tarr
Encompass Health Corporation - CEO, President & Director

It's great to be here.

Questions & Answers

Andrew Mok
UBS Investment Bank, Research Division - Analyst

To start, Mark, IRF volumes have been very strong in recent quarters, including 8% discharge growth in the first quarter of this year. How should we think about the sustainability of that volume growth?

Mark J. Tarr
Encompass Health Corporation - CEO, President & Director

Yes. So we do think it's sustainable. If you look at the underlying factors, by the way, first quarter was a very challenging quarter. So we were very proud of the volume that we had in both the IRF and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot